Industry reports
Editor highlights

Drug Discovery and Development Industry Market Research Reports in Japan, April 2014

You might be interested in: clinical trial, drug discovery, drug development, more »

» View Public Reports

1-30 of 81 reports

ICON PLC - Company Report for Year 2014

  • Company report
  • March 2014
  • 2 pages
  • by Corporation
  • Industries: Drug Discovery and Development
  • Countries: Japan

Company Report: Drug Discovery and Development in Japan for Year 2013

  • Company report
  • December 2013
  • 2 pages

... For the company. . (2) There have been no changes to movements by pharmaceutical companies for use of external resources towards efficiency and swiftness of their new drug development. The company's main cro ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Company Report: Clinical Trial in Japan, Canada and South Korea for Year 2013

  • Company report
  • November 2013
  • 4 pages
  • by Corporation

... Cel expects to have two concurrent rch-01 human clinical trials which will significantly increase the available human clinical data on rch-01. Rci-02: replicel has designed and is developing a new cell ...

  • Industries: Drug Discovery and Development
  • Countries: Japan, Canada, South Korea

Clinical Study Production and Trade Statistics in Japan and China

  • Industry report
  • November 2013
  • 46 pages

... Partners college of american pathologists (cap) certified gcp-comliant technology & research development facilities exploratory basic research drug discovery non-clinical study utilizing small ...

  • Industries: Drug Discovery and Development
  • Countries: Japan, China

Trans Genic Inc. - Company Report for Year 2013

  • Company report
  • July 2013
  • 3 pages

... Condition model mouse, and aims to contribute to the society by supporting totally research and development for drug discovery, from basic research such as seeds-exploration through preclinical study ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Trans Genic Inc. - Company Report for Year 2013

  • Company report
  • July 2013
  • 3 pages

... Condition model mouse, and aims to contribute to the society by supporting totally research and development for drug discovery, from basic research such as seeds-exploration through preclinical study ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Fuso Pharmaceutical Industries Ltd. - Company Report for Year 2013

  • Company report
  • June 2013
  • 33 pages

... Pharmaceutical companies when the agreement is signed, while milestone payments are generated in the development process when certain goals are achieved. This is the same as with conventional drug-discovery ...

  • Industries: Drug Discovery and Development
  • Countries: Japan, United States

Company Report: Clinical Trial in Japan and The United States for Year 2013

  • Company report
  • June 2013
  • 14 pages

... Relationship with our partners in korea and taiwan as well as business development in other asian countries. As to our second pipeline, dental bone filler (tdm-711), the clinical trial is underway at forsyth ...

  • Industries: Drug Discovery and Development
  • Countries: Japan, United States

Clinical Trial Production and Trade Statistics in Japan and India

  • Industry report
  • May 2013
  • 45 pages

... clinical trial trends outline complexity for supply chain scott ohanesian, vp commercial operations apac email: 29 may 2013 biotechnology sales on the rise 29 may ...

  • Industries: Drug Discovery and Development
  • Countries: World, Japan, India

Clinical Trial in Japan : Innovation and Technology Trends

  • Industry report
  • April 2013
  • 32 pages

... And insurance for clinical research besides trials a lot of clinical research not covered by the pharmaceutical affairs act is conducted in many education-related hospitals such as university hospitals ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Company Report: Clinical Trial in Japan for Year 2013

  • Company report
  • April 2013
  • 12 pages
  • Industries: Drug Discovery and Development
  • Countries: Japan

Fuso Pharmaceutical Industries Ltd. - Company Report for Year 2013

  • Company report
  • March 2013
  • 28 pages

... Costs were to increase as multiple clinical trials are conducted simultaneously). 3Dm was planning on starting clinical trials for several pipeline applications, such as its alveolar bone reconstruction ...

  • Industries: Drug Discovery and Development
  • Countries: Japan, United States, South Korea

Company Report: Drug Discovery and Development in Japan and The United States for Year 2013

  • Company report
  • March 2013
  • 41 pages
  • by Corporation

... To the growth process of assets and patent stocks. As pisano (2006) pointed out among others, biotech is characterized as an industry facing profound and persistent uncertainty, which makes drug research ...

  • Industries: Drug Discovery and Development
  • Countries: Japan, United States

Investor presentation: Drug Discovery and Development in Denmark and Japan for Year 2012

  • Company report
  • December 2012
  • 12 pages
  • by Corporation

... Include, among others, risks associated with product discovery and development, uncertainties related to the outcome of clinical trials, slower than expected rates of patient recruitment, unforeseen safety ...

  • Industries: Drug Discovery and Development
  • Countries: Denmark, Japan

Allotment - Investment Analysis, December 2012

  • Company report
  • December 2012
  • 5 pages

... Potential. Building a pipeline with multiple drug cands for underserved markets with orphan-like indications and lower competition will enable symbio to achieve steady growth. As such, sym ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Company Report: Clinical Trial in Japan and The United States for Year 2012

  • Company report
  • November 2012
  • 3 pages
  • by Corporation

... Stage product cands; progress of product cands in clinical trials and regulatory approvals as it relates to receiving future milestone payments; inability of our existing collaborators to effectively ...

  • Industries: Drug Discovery and Development
  • Countries: Japan, United States

The Japanese Clinical Trial Market : Innovation and Technology Trends

  • Industry report
  • October 2012
  • 21 pages
  • by Non Governmental Organization (NGO)

... Standards Summary: Using cdisc standards can save significant time and cost, especially when implemented in the early stages of the study Opportunities for an additional impact on clinical ...

  • Industries: Drug Discovery and Development
  • Countries: World, Japan

Fuso Pharmaceutical Industries Ltd. - Company Report for Year 2012

  • Company report
  • September 2012
  • 32 pages

... As a treatment for spontaneous bone cancer through pre-clinical trials. The company added this project could have significant impact on worldwide cancer stem cell research, mirna research and many other clinical ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Company Report: Drug Discovery and Development in Japan for Year 2012

  • Company report
  • September 2012
  • 14 pages

... Of clinical testing. According to the company s ceo, dr. Ryo kubota, if the company is success- ful in this drug discovery project, it expects to be able to save 120 million people from blindness around ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Company Report: Drug Discovery and Development in Japan for Year 2012

  • Company report
  • August 2012
  • 2 pages

... And release of new drugs. In addition, the japanese government implements initiatives to stimulate clinical trials aiming at promoting innovative drug development and reducing the so-called "drug lag ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Fuso Pharmaceutical Industries Ltd. - Company Report for Year 2012

  • Company report
  • June 2012
  • 29 pages

... clinical trials for tdm-711 have been performed at forsyth institute affiliated with harvard school of dental medicine since february 2012. According to the announcement, the company has completed ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Company Report: Clinical Trial in Japan for Year 2012

  • Company report
  • June 2012
  • 12 pages

... As to our second pipeline, dental bone filler (tdm-711), our subsidiary acquired ide approval from the us food and drug administration in july, 2011 and the clinical trial started at forsyth institute ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Company Report: Clinical Trial in The United States and Japan for Year 2012

  • Company report
  • June 2012
  • 9 pages

... Basis). In the cro business, linical specializes in the most vital stages of clinical trials of phase ii and iii studies including major activities such as monitoring, quality control, and consulting ...

  • Industries: Drug Discovery and Development
  • Countries: United States, Japan, World

Company Report: Clinical Trial in Japan for Year 2012

  • Company report
  • June 2012
  • 10 pages

... Was allocated to operating revenue. As to our second pipeline, dental bone filler (tdm-711), our subsidiary acquired ide approval from food and drug administration in july, 2011 and the clinical trial started ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Investor presentation: Drug Discovery and Development in Canada, India and Japan for Year 2012

  • Company report
  • June 2012
  • 17 pages

... Science ingredients (48%) life science chemicals healthcare specialty pharma nutrition ingredients generics proprietary products & exclusive synthesis active pharma ingredients drug discovery ...

  • Industries: Drug Discovery and Development
  • Countries: Canada, India, Japan

Fuso Pharmaceutical Industries Ltd. - Company Report for Year 2012

  • Company report
  • April 2012
  • 39 pages
  • Industries: Drug Discovery and Development
  • Countries: Japan

Company Report: Clinical Trial in Japan for Year 2012

  • Company report
  • April 2012
  • 11 pages

... Will increase as we promote research and development, including clinical trials, for developing pipelines. We have secured these funds by public offering upon stock listing, and we will make efforts to ensure ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

The Japanese Clinical Trial Market : Innovation and Technology Trends

  • Industry report
  • March 2012
  • 223 pages

... clinical trials. The medium range plan includes the International strategic plan As the basic policy for the agency S international activities and the already developed Pmda vision ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Clinical Trial in Japan : Innovation and Technology Trends

  • Industry report
  • March 2012
  • 20 pages

... trials are regarded appropriate demand if criteria are met available in us,uk, ge,fr opinion evaluation of necessity of clinical trials and other studies clinical trials csimc reflection on drug ...

  • Industries: Drug Discovery and Development
  • Countries: Japan

Investor presentation: Drug Discovery and Development in India, The United States and Japan for Year 2012

  • Company report
  • March 2012
  • 31 pages
  • by Corporation
  • Industries: Drug Discovery and Development
  • Countries: India, United States, Japan

» Purchase Premium Reports (From $ 125 - $ 125)

41 reports

Japan Phase I Clinical Trials

January 2013 $ 250

Japan Phase Ii Clinical Trials

January 2013 $ 250

Japan Total Clinical Trials

January 2013 $ 250

Japan Phase Iii Clinical Trials

January 2013 $ 250

Emerging Nipt Market In Asia Pacific

November 2013 $ 1 200

Fracture - Pipeline Review, H2 2013

September 2013 $ 2 000

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.